Swedish Orphan Biovitrum AB (publ)(Sobi) has announced that Lars Dreiøe has been appointed Senior Vice President Chief Quality & Compliance Officer (CQCO). Lars Dreiøe joins Sobi from global pharmaceutical company ALK in Denmark where he has been International Head of Quality.
Lars Dreiøe joins Sobi as Senior Vice President, Chief Quality & Compliance Officer
Lars brings 20 years of experience in the Biotech and Pharmaceutical industry in the Quality, Manufacturing, Product Safety and Regulatory Affairs areas.
"We are delighted to welcome Lars to Sobi," said Geoffrey McDonough, President and CEO at Sobi. "Sobi has been expanding the scope and geographic area of operations and the demands and complexity of external regulations governing our business has also increased. Lars will sustain and deepen our global commitment to quality in all aspects of our work, and will be a valuable addition to our senior leadership team."
"I'm very much looking forward to joining the team at Sobi and to entering my new role - developing and delivering therapies at the highest level of quality to people living with a rare disease," said Lars Dreiøe.
Lars will join Sobi on 18 January 2016.
Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients.